The US regulator has started a review of Roche's supplemental biologics license application (BLA) for Gazyva/Gazyvaro ...

The decision to acquire Chimerix comes just a few months after Jazz claimed FDA approval for Ziihera (zanidatamab), its ...

After six years at the helm of the Medicines and Healthcare products Regulatory Agency (MHRA), Dame June Raine will step down ...

Welcome to the first edition of Changing Faces for 2025. January kicked off the year with a flurry of notable leadership ...

The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto, which brought in ...

Anderson is expecting 2025 to be a pivotal year for his turnaround plan – which revolves around the removal of management ...